According to Australian Bureau of Statistics, as of 30th June 2020, there were approximately 4.2 million 60 and above aged people in Australia, comprising of about 16% of total population of Australia.
Also, the consumers are now much aware regarding the ill effects of untreated and undiagnosed sleep apnea and are inclined toward gathering more information and being prepared therefore supporting the growth of the Australia Sleep Apnea Devices market in the coming years. The demand for early diagnosis and effective treatment is also aiding the growth of the market. Research and technological advancement in providing better and effective devices for the diagnosis and treatment of sleep apnea is substantiating the growth of the Australia Sleep Apnea Devices market in the forecast period, 2024-2028.
Furthermore, changed lifestyle, prolonged daily schedules, and cases of insomnia are also aiding to the rising number of cases for sleep apnea and thus supporting the growth of Australia Sleep Apnea Market. Moreover, advancing technology for diagnostic devices is further supporting the growth of the market in the coming years.
Growing Prevalence of Sleep Apnea
According to Australian Institute of Health and Welfare, the total health system cost of obstructive sleep apnea is approximately 541 USD million which comprise 57% of total health system cost of sleep disorders i.e., 944 USD million in 2019-2020. Approximately 1 in 4 men over the age of 30 in Australia, or 5% of the population, suffer from sleep apnea. Men have the disease nearly three times as often as women in the over-30 age group.
Introduction of Advanced Devices for Sleep Apnea
The Therapeutic Goods Administration (TGA) of Australia has granted Vivos Therapeutics several Class I certifications for a variety of purposes, including the treatment of snoring and mild, moderate, and severe obstructive sleep apnea in both adults and children.
Market Segmentation
Australia sleep apnea devices market is segmented based on type, indication, end-user, region. Based on type, the market is further divided between therapeutic and diagnosis. Based on indication, the market is divided into obstructive sleep apnea and central sleep apnea. Based on end user, the market is further segmented into hospitals & clinics, homecare and others.
Market Players
Fisher & Paykel Healthcare Corporation Limited, SomnoMed Limited, Compumedics Limited, ResMed Inc (Australia), Philips Australia, Oventus Medical Australia
Attribute | Details |
Base Year | 2022 |
Historic Data | 2018 – 2021 |
Estimated Year | 2023 |
Forecast Period | 2024 – 2028 |
Quantitative Units | Revenue in USD Million and CAGR for 2018-2022 and 2023-2028 |
Report Coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered | · Type · Indication · End User |
Regional Scope | Capital Territory & New South Wales; Victoria & Tasmania; Western Australia; Queensland; Northern Territory & Southern |
Key Companies Profiled | Fisher & Paykel Healthcare Corporation Limited, SomnoMed Limited, Compumedics Limited, ResMed Inc (Australia), Philips Australia, Oventus Medical Australia, WellOZ Australia, Bespoke Medical Innovations Pty Ltd, DeVilbiss Healthcare Pty Ltd., Invacare Australia Pty Ltd. |
Customization Scope | 10% free report customization with purchase. Addition or alteration to regional & segment scope. |
Pricing And Purchase Options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |